Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions

被引:126
作者
Li, CY
Dandridge, KS
Di, A
Marrs, KL
Harris, EL
Roy, K
Jackson, JS
Makarova, NV
Fujiwara, Y
Farrar, PL
Nelson, DJ
Tigyi, GJ
Naren, AP [1 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA
[2] Univ Tennessee, Hlth Sci Ctr, Dept Comparat Med, Memphis, TN 38163 USA
[3] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA
关键词
D O I
10.1084/jem.20050421
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel localized primarily at the apical or luminal surfaces of epithelial cells that line the airway, gut, and exocrine glands; it is well established that CFTR plays a pivotal role in cholera toxin (CTX)-induced secretory diarrhea. Lysophosphatidic acid (LPA), a naturally occurring phospholipid present in blood and foods, has been reported to play a vital role in a variety of conditions involving gastrointestinal wound repair, apoptosis, inflammatory bowel disease, and diarrhea. Here we show, for the first time, that type 2 LPA receptors (LPA(2)) are expressed at the apical surface of intestinal epithelial cells, where they form a macromolecular complex with Na+/H+ exchanger regulatory factor-2 and CFTR through a PSD95/Dlg/ZO-1-based interaction. LPA inhibited CFTR-dependent iodide efflux through LPA(2)-mediated G(i) pathway, and LPA inhibited CFTR-mediated short-circuit currents in a compartmentalized fashion. CFTR-dependent intestinal fluid secretion induced by CTX in mice was reduced substantially by LPA administration; disruption of this complex using a cell-permeant LPA(2)-specific peptide reversed LPA(2)-mediated inhibition. Thus, LPA-rich foods may represent an alternative method of treating certain forms of diarrhea.
引用
收藏
页码:975 / 986
页数:12
相关论文
共 58 条
  • [21] Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes
    Fischer, DJ
    Liliom, K
    Guo, Z
    Nusser, N
    Virág, T
    Murakami-Murofushi, K
    Kobayashi, S
    Erickson, JR
    Sun, GP
    Miller, DD
    Tigyi, G
    [J]. MOLECULAR PHARMACOLOGY, 1998, 54 (06) : 979 - 988
  • [22] A soy-derived antiapoptotic fraction decreases methotrexate toxicity in the gastrointestinal tract of the rat
    Funk-Archuleta, MA
    Foehr, MW
    Tomei, LD
    Hennebold, KL
    Bathurst, IC
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1997, 29 (03): : 217 - 221
  • [23] CYSTIC-FIBROSIS HETEROZYGOTE RESISTANCE TO CHOLERA-TOXIN IN THE CYSTIC-FIBROSIS MOUSE MODEL
    GABRIEL, SE
    BRIGMAN, KN
    KOLLER, BH
    BOUCHER, RC
    STUTTS, MJ
    [J]. SCIENCE, 1994, 266 (5182) : 107 - 109
  • [24] Goodman L, 1999, Dis Mon, V45, P268
  • [25] STIMULATION OF ELECTROLYTE SECRETION IN RABBIT COLON BY ADENOSINE
    GRASL, M
    TURNHEIM, K
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1984, 346 (JAN): : 93 - 110
  • [26] MEDICAL PROGRESS - BACTERIAL AND PROTOZOAL GASTROENTERITIS
    GUERRANT, RL
    BOBAK, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) : 327 - 340
  • [27] Adenosine:: an endogenous regulator of innate immunity
    Haskó, G
    Cronstein, BN
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (01) : 33 - 39
  • [28] Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells
    Huang, PB
    Lazarowski, ER
    Tarran, R
    Milgram, SL
    Boucher, RC
    Stutts, MJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 14120 - 14125
  • [29] PDZ domains: Structural modules for protein complex assembly
    Hung, AY
    Sheng, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) : 5699 - 5702
  • [30] Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate
    Im, DS
    Heise, CE
    Harding, MA
    George, SR
    O'Dowd, BF
    Theodorescu, D
    Lynch, KR
    [J]. MOLECULAR PHARMACOLOGY, 2000, 57 (04) : 753 - 759